SEC Contract Filing

Filing Date: 2016-08-08

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>atra-ex102_415.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
atra-ex102_415.htm
</title>
</head>
<!-- NG Converter v4.0.3.7 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;text-indent:0%;">Exhibit 10.2</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:0%;">ATARA BIOTHERAPEUTICS, INC.</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">2014 EQUITY INCENTIVE PLAN</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-variant: small-caps;font-weight:normal;font-style:normal;text-transform:none;">First Amended and Restated:&nbsp;&nbsp;May 28, 2014</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-variant: small-caps;font-weight:normal;font-style:normal;text-transform:none;">Second Amended and Restated:&nbsp;&nbsp;__________, 2016</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-variant: small-caps;font-weight:normal;font-style:normal;text-transform:none;">Approved by the Stockholders:&nbsp;&nbsp;__________, 2016</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-variant: small-caps;font-weight:normal;font-style:normal;text-transform:none;">Effective Date:&nbsp;&nbsp; __________, 2016</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:6.67%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:bold;font-variant: small-caps;font-style:normal;text-transform:none;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:bold;font-variant: small-caps;font-style:normal;text-transform:none;">1.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;color:#000000;font-weight:bold;font-variant: small-caps;font-style:normal;text-transform:none;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;">General.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font>Successor to and Continuation of Prior Plans.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:13.33%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:36pt;"></font><font style="font-weight:normal;">The Plan is the successor to and continuation of the Nina Biotherapeutics, Inc. 2012 Equity Incentive Plan, the Pinta Biotherapeutics, Inc. 2012 Equity Incentive Plan, and the Santa Maria Biotherapeutics 2012 Equity Incentive Plan, as amended (collectively, the &#8220;</font><font style="font-style:italic;">Prior Plans</font><font style="font-weight:normal;">&#8221;).&nbsp;&nbsp;From and after 12:01 a.m. Pacific time on the Original Effective Date, no additional stock awards will be granted under the Prior Plans.&nbsp;&nbsp;All stock awards granted under the Prior Plans remain subject to the terms of the Prior Plans.&nbsp;&nbsp;All Awards granted on or after 12:01 a.m. Pacific Time on the Original Effective Date are subject to the terms of this Plan.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:13.33%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:36pt;"></font><font style="font-weight:normal;">Any shares that would otherwise remain available for future grants under any of the Prior Plans as of 12:01 a.m. Pacific Time on the Original Effective Date ceased to be available under the Prior Plans at such time.&nbsp;&nbsp;Instead, that number of shares of Common Stock equal to the number of shares of the Company then available for future grants under the Prior Plans (the &#8220;</font><font style="font-style:italic;">Prior Plans&#8217; Available Reserve</font><font style="font-weight:normal;">&#8221;) was added to the Share Reserve (as further described in Section&#160;3(a) below) and became immediately available for grants and issuance pursuant to Stock Awards under this Plan, up to the maximum number set forth in Section&#160;3(a) below.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:13.33%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:36pt;"></font><font style="font-weight:normal;">From and after 12:01 a.m. Pacific time on the Original Effective Date, a number of shares of Common Stock equal to the total number of shares of common stock subject to outstanding stock awards granted under the Prior Plans that (A)&#160;expire or terminate for any reason prior to exercise or settlement, (B)&#160;are forfeited because of the